Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients

Efficacy of Combined Bevacizumab and Angiotensin-Converting Enzyme Inhibitors or Angiotensin II type 1 Receptor Blockers in Metastatic Colorectal Cancer Patients

Background: Bevacizumab, used in the treatment of metastatic colorectal cancer (mCRC), has an angiogenesis inhibitory effect. Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II type 1 receptor blockers (ARBs) used in the treatment of arterial hypertension demonstrate antitumoural eff...

Full description

Saved in:
Bibliographic Details
Main Authors: Ali Kaan Güren, Nargiz Majidova, İclal Çakır, Nadiye Sever, Erkam Kocaaslan, Pınar Erel, Yeşim Ağyol, Abdussamed Çelebi, Rukiye Arıkan, Selver Işık, Murat Sarı, Özlem Ercelep, İbrahim Vedat Bayoğlu, Osman Köstek
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2025-04-01
Series:Middle East Journal of Cancer
Subjects:
colorectal neoplasms
bevacizumab
angiotensin-converting enzyme inhibitors
angiotensin ii type 1 receptor blockers
Online Access:https://mejc.sums.ac.ir/article_50297_afb2a38d11319337faa28ede8ca21b21.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items